Font Size: a A A
Keyword [Nonvalvular atrial fibrillation]
Result: 21 - 40 | Page: 2 of 7
21. The Clinical Study Of Different Antithrombotic Therapies In Different Risk Patients With Non-valvular Atrial Fibrillation
22. CHA2DS2-VASc Score Is Predictive Of Left Atrial Or Left Atrial Appendage Thrombus In Nonvalvular Atrial Fibrillation
23. Application Of Combining Asprin With Dipyridamole To Prevent Thromboembolic Events In Patients With Nonvalvular Atrial Fibrillation
24. A Retrospective Case Series Study On The Clinical Characteristics And Anticoagulation Therapy Of Patients With Cardiogenic Cerebral Embolism
25. The Correlation Between CHADS2 Scores And The Degree Of Cerebral Atherosclerosis And The Prognosis Of Stroke
26. Research On The Related Risk Factors In Smoking Patients With Nonvalvular Atrial Fibrillation
27. The Expression Levels And Clinical Significance Of Plasma MiR-1 And MiR-133a In Patients With Nonvalvular Atrial Fibrillation
28. Percutaneous Left Atrial Appendage Closure For Prevention Of Stroke In Nonvalvular Atrial Fibrillation:A Systematic Review And Meta-analysis
29. Efficacy And Safety Analysis Of Catheter Ablation Combined With Left Atrial Appendage Occlusion In Patients With Nonvalve Atrial Fibrillation
30. The Prevention Of New Progress In The Treatment Of Cerebral Stroke With Nonvalvular Atrial Fibrillation
31. The Use Status Of Anticoagulation Drugs For Patients With Nonvalvular Atrial Fibrillation In Hospitals Of Chongqing: A Cross-sectional Study
32. Clinical Research Of Left Atrial Appendage Occlusion In Patients With Nonvalvular Atrial Fibrillation
33. Systematic Review And Meta Analysis Of Stroke And Bleeding Risk Scores For Patients With Nonvalvular Atrial Fibrillation
34. The Retrospective Investigation Of 2442 Cases Of Hospitalized Patients With Nonvalvular Atrial Fibrillation
35. The Significance Of Von Willebrand Factor In Patients With Non-Valvular Atrial Fibrillation
36. The Research About The Expression Level Of Plasma Galectin-3 In Patients With Nonvalvular Atrial Fibrillation
37. The Change Of MicroRNA-29b And MMP-9 In Patient With Nonvalvular Atrial Fibrillation
38. The Investigation And Analysis Of Hospitalized Patients With Nonvalvular Atrial Fibrillation : The Primary Prevention Of Stroke In Chengdu
39. Analysis Of Risk Factors For Left Atrium/Left Atrial Appendage Thrombosis In Patients With Nonvalvular Atrial Fibrillation
40. Efficacy And Safety Of Dabigatran And Rivaroxaban In Patients With Nonvalvular Atrial Fibrillation :a Meta-Analysis
  <<First  <Prev  Next>  Last>>  Jump to